The project is funded by the Reproductive Health Supplies Coalition (RHSC) and implemented by International Centre for Reproductive Health–Kenya (ICRHK) in Kakamega, Kisumu, Nakuru, Kitui, Kilifi, Kiambu, and Nairobi counties.
The project seeks to scale up access to new and lesser-used medicines for postpartum hemorrhage (NLUM–PPH) to prevent and treat PPH, the leading cause of maternal deaths in Kenya and globally. It promotes the use of heat-stable carbetocin (HSC), tranexamic acid (TXA), and misoprostol, which are effective, evidence-based, and easy-to-administer medicines that do not require refrigeration, making them ideal for low-resource settings.

Impact Through this project, ICRHK has:

• Strengthened national and county leadership to adopt and integrate new PPH medicines into health systems.
• Trained and mentored 525 healthcare providers across seven counties, equipping them with lifesaving knowledge and tools.
• Enabled over 52,000 women to receive safer, higher-quality maternal care.
• Protected 46,000+ mothers using heat-stable carbetocin and tranexamic acid, even in facilities without refrigeration or reliable electricity.
• Supported facilities, such as those in Kiambu and Makueni, have recorded zero maternal deaths from PPH for several consecutive months.
• Contributed to the national adoption of HSC in 45 out of 47 counties, demonstrating rapid, scalable progress toward ending preventable maternal deaths.

Through strong partnerships with the Ministry of Health, county Departments of Health, Jacaranda Health, and frontline healthcare providers, the project has strengthened Kenya’s capacity to manage postpartum hemorrhage and save mothers’ lives nationwide.